✦ LIBER ✦

Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)

✍ Scribed by Paul, C.; Puig, L.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J.-F.; Rizova, E.; Lavie, F.; Mistry, S.; Bergmans, P.; Barker, J.; Reich, K.

Book ID: 126490883
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 211 KB
Volume: 170
Category: Article
ISSN: 0007-0963
DOI: 10.1111/bjd.12646

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

One-year safety and efficacy of ustekinu

One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis

✍ Reich, K.; Puig, L.; Paul, C.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB

PSS28 Long-Term Improvement in Patient-R

PSS28 Long-Term Improvement in Patient-Reported Outcomes After Transition From Methotrexate to Ustekinumab in Moderate to Severe Psoriasis: Transit Week 52 Results

✍ Reich, K.; Puig, L.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicol 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Ustekinumab treatment in patients with m

Ustekinumab treatment in patients with moderate to severe psoriasis who are nonresponders to etanercept: Results from a phase III clinical trial

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Fumarates vs. methotrexate in moderate t

Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial

✍ S. Fallah Arani; H. Neumann; W.C.J. Hop; H.B. Thio 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

Etanercept therapy allows tapering of me

Etanercept therapy allows tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Clinical response to adalimumab treatmen

Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study

✍ Kenneth B. Gordon; Richard G. Langley; Craig Leonardi; Darryl Toth; M. Alan Ment 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 273 KB